MYM Nutraceuticals Inc, (CSE: MYM) (OTCBB: MYMMF), a Canada-based company focused on the global growth of Cannabis and CBD-rich hemp, has named its current executives, Mark Forster and Paul Cheetham, as CFO and COO respectively of MYM International Brands Inc, it is reported today.
Both executives have transferred from MYM Nutraceuticals to the International Brands team to launch global expansion efforts of CBD-rich consumer products in a wide variety of categories, including food and beverage, pharmaceuticals, cosmetics, and health and wellness.
The company has also requested one of its present independent directors, Andrew Kent, to offer assistance by serving on the board of International Brands as an independent director, and accordingly he will step down as an independent director of the company while in that new capacity.
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'